Some leading US obesity specialists say they expect Eli Lilly’s powerful weight-loss drug Zepbound will produce the same or similar heart benefits as Novo Nordisk’s popular Wegovy.
Some leading U.S. obesity specialists
say they expect Eli Lilly’s powerful weight-loss drug
Zepbound will produce the same or similar heart benefits as Novo
Nordisk’s popular Wegovy as they belong.
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.